This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
Virtual event, Worldwide : 26 - 27 April 2022
Chapin Rodriguez
Director, Creaducate Consulting
A. Chapin Rodríguez (BSc, Duke University, USA; PhD, Cambridge University, UK) has conducted research at the MRC Laboratory of Molecular Biology (UK) and the Harvard Institutes of Medicine (USA). His research has been funded by the Howard Hughes Medical Institute, the US National Institutes of Health and the UK Medical Research Council. He has worked more than 14 years as a consultant in science communication and publishing, helping researchers in natural and clinical sciences publish their manuscripts in peer-reviewed journals, prepare grant applications and improve their oral presentation skills. He is the founder of Creaducate Consulting (www.creaducate.eu).
Ellen Wilson
Scientific Editor, Life Science Editors
Ellen obtained her Ph.D. at the Institute of Molecular Biology at the University of Oregon, characterizing the regulatory regions of genes transcribed by Polymerase III. She joined Princeton University as a postdoctoral fellow, where she studied genetic regulation of gastrulation in the fruit fly, work that was published in Cell. She next shifted to early development of the zebrafish, studying cell fate choices and gastrulation and publishing her findings in Science, Trends in Genetics, and elsewhere. Subsequently, she won grants from HHMI and NIH to produce internet-based science education curricula and then spent twenty years in Research Development at Huntsman Cancer Institute, an NCI-designated comprehensive cancer center. At HCI, she was an expert in all aspects of the Cancer Center Support Grant (P30) and was an author and scientific editor of that grant, as well as many others designed to fund strategic institutional initiatives. In addition, she contributed to and edited proposals for large, complex, or multi-project grants from HCI’s cancer center members. She joined Life Science Editors in 2021.
María M. Caffarel
Ikerbasque and Miguel Servet Fellow, Biodonostia Health Research Institute
María works as a Principal Investigator (Ikerbasque and Miguel Servet Fellow) in Biodonostia Health Research Institute, San Sebastian, Spain, where she leads the Breast Cancer Group. Her research is focused on the role of inflammation in breast cancer progression, in order to design new therapeutic strategies. María got her PhD in Madrid (Universidad Complutense) and spent 5.5 years as a Postdoctoral researcher at the University of Cambridge (UK).
She is a member of ASEICA (Spanish Association for Cancer Researcher) Board of Directors, where she coordinates ASEICA Young. María is also President of Biodonostia Gender Equality Committee and enjoys participating in outreach and science dissemination activities with cancer patients’ charities and the general public.
Verónica Torrano
Principal Investigator, Department of Biochemistry and Molecular Biology, University of the Basque Country
Verónica is Principal Investigator (Ramón y Cajal Investigator) in the Department of Biochemistry and Molecular Biology at the University of Basque Country (Spain), where she leads the Cancer Transcription and Cell Communication Laboratory. Her research interests are focus on the study of transcriptional deregulation of cellular communications in the context of tumor microenvironment and its impact on prostate cancer progression. Verónica did her PhD in Biochemistry & Molecular Biology at the University of Cantabria (Spain) and spent more than 10 years as postdoctoral
researcher, first at The Institute of Cancer Research (UK, 2008-2011) and later at CICbioGUNE (Spain, 2011-2019).
Along her career, Verónica has been awarded with the Lady Tata Award-2006, L’Oréal For Women in Science Spanish Award 2019 and the XX FERO-Award 2021. Since 2019, she is member of ASEICA (Spanish Association for Cancer Researcher) Board of Directors, where she coordinates ASEICA Young working group. In this position Verónica and her colleagues have promoted the start-up of different outreach activities, such as a Mentoring program and Leadership Courses for Young IP.
Toni Celià-Terrassa
Group Leader of the Cancer Stem Cells & Metastasis Dynamics Lab, Hospital del Mar Medical Research Group
Group Leader of the Cancer Stem Cells & Metastasis Dynamics Lab at the Hospital del Mar Medical Research Institute (IMIM); Cancer Program. He obtained the Miguel Servet grant and incorporated the IMIM in January 2018. His lab focuses on Breast cancer, metastasis dynamics and immunotherapy research.
He obtained his Ph.D. in 2012 by the University of Barcelona at the IBMB-CSIC under the supervision of Dr. Timothy Thomson. During this period his studies unveiled groundbreaking concepts about the implications of epithelial-to-mesenchymal transition (EMT) and its reversion during the metastatic colonization of distant tissues. In 2012, he moved to Princeton (NJ, USA) where he was a Postdoctoral Fellow at Dr. Yibin Kang´s Lab; Princeton University (2012-2017). Specialized in breast cancer metastasis research, he studied the intricate molecular mechanisms of normal and malignant mammary stem cells to shield from immune system signals in breast cancer, as well as the spatiotemporal dynamics of EMT-MET in metastasis.
Christian Frezza
Professor of Metabolomics, CECAD, University of Cologne
Christian is the Alexander von Humboldt Professor of Metabolomics in Ageing, at CECAD, at the University of Cologne. He studied Medicinal Chemistry at the University of Padova, Italy, and gained his MSc in 2002, after a period of research on mitochondrial toxicity induced by photoactivable anticancer drugs. Christian then joined the laboratory of Luca Scorrano in Padova to start a PhD on mitochondrial dynamics and apoptosis. In 2008, he moved to the Beatson Institute of Cancer Research in Glasgow as recipient of an EMBO Long Term Fellowship, where he investigated the role of mitochondrial defects in tumorigenesis. He moved to the MRC Cancer Unit in 2012 as tenure track Group Leader and became a Programme Leader in 2017. In 2021 he moved to CECAD to establish his laboratory in Germany.
His laboratory is mainly interested in investigating the emerging connection between cancer and metabolism, with a particular focus on mitochondrial metabolism. By using a combination of biochemistry, metabolomics, and systems biology he investigates the role of altered metabolism in cancer with the aim to understand how metabolic transformation regulates the process of tumorigenesis. His aim is to exploit these findings to establish novel therapeutic strategies and diagnostic tools for cancer.
Jane Smith
Chief Executive Officer, European Association for Cancer Research
Jane is the Chief Executive Officer of the EACR, working with the EACR Board and leading the staff team based at the HQ in the UK. After graduating from the University of York, Jane’s early career was in local government followed by a career in higher education management, with a focus on pharmacy education and international partnerships. In 2013 Jane became Director of Qualifications and Standards at the British Psychological Society, and from there moved to the EACR in 2016.
Heike Allgayer
Professor and Director, Department of Experimental Surgery - Cancer Metastasis, University of Heidelberg
Prof. Dr. med. Heike Allgayer, MD, PhD, (current total IF>1130, H-Index 54), is the Department Head of Experimental Surgery and Cancer Metastasis at the Mannheim Medical Faculty of University of Heidelberg, Germany, additionally serving as Vice Director of the Centre for Biomedicine and Medical Technology (CBTM), Mannheim Medical Faculty, Ruprecht-Karls- University of Heidelberg, from 2018-2020. She received her MD and Dr. med. (summa cum laude) at Ludwig-Maximilians University Munich in 1995/1996, and her PhD (in molecular biology) at the University of Houston-MD Anderson Cancer Center in 1999. As a board-certified surgeon and molecular biologist she sees her mission in bridging basic research and the treatment of cancer patients as a dedicated translational researcher. Her major research interests include molecular determinants defining metastasis, microRNAs in metastasis, molecular determinants of response to novel therapeutics, metastasis prevention, translational metastasis research, and molecular staging of cancer.
Verena Jendrossek
Vice-Chair of the Institute of Cell Biology and Head of the Molecular Cell Biology Group, University of Essen
Based at University Hospital Essen, Prof. Dr. Verena Jendrossek's research focuses on molecular mechanisms of chemo- and radio-therapy-induced cell death and tumor cell intrinsic resistance mechanisms, microenvironment-mediated treatment resistance, and radiation-induced pneumonitis as well as the phosphatidylinositol-3-kinase pathway as a target for the modulation of therapy response. She has a series of ongoing major projects linked to these research focuses. Verena has served as an EACR Board Member and was a founding member in 2012 of the EACR Conference Committee (formerly Education Committee).
Neta Erez
Associate Professor, Chair of the Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University
Prof. Neta Erez is the Head of the Laboratory of Tumor Biology and Chair of the Department of Pathology in the Sackler School of Medicine at Tel Aviv University. She has been involved in cancer research from the earliest stages of her research career, and has been funded continuously by ICRF since 2011.
Prof. Erez’s goal is to understand how cells in the microenvironment of tumors – in particular, fibroblasts and immune cells – facilitate the growth of metastatic tumor cells. To date, most anti-cancer therapy is applied following operative resection of the primary tumor, in order to prevent disease relapse; thus, making the microenvironment at the metastatic organ an important target for therapy. Moving forward, she hopes to discover molecular pathways that would lead to the development of novel therapies to efficiently inhibit the development of breast cancer metastases.
Phillipa Timmins
Sales Manager EMEIA, Scientifica
Dr Phillipa Timmins received her PhD in inorganic chemistry from the University of York in 2003. She then followed a successful career in scientific instrumentation sales with roles in X-ray diffraction, Motion capture, Microscopy, Microfluidics, Spectroscopy and Confocal Imaging before joining Scientifica in 2021. She now heads up the EMEIA sales team at Scientifica, with responsibility for sales of their premier range of electrophysiology and multiphoton equipment. In her spare time she runs a smallholding, where she is custodian of a number of rare breed animals including her show winning British Saddleback pigs.
Sven Lindemann
Senior Innovation Manager (EU), Strategic Innovation, Merck KGaA, Darmstadt, Germany
Dr. Sven Lindemann received a PhD in Neurobiology at the Brain Research Institute of the University of Bremen. He continued as Research Scientist at the Hanse-Wissenschaftskolleg and Postdoc at the University of Veterinary Medicine in Hannover. The following 2 years, he worked as a LabHead at the International Neurosciences Institute Hannover. He started his Industry Career at Sanofi-Aventis in 2006. In 2009 he changed to Merck as a Principal Scientist and later as Head of Exploratory Osteoarthritis. Since 2020 he is a member of the Strategic Innovation team at Merck. The team is responsible for external scientific collaborations, future game changers and driving the innovation strategy in healthcare but also cross sector.
For more information on our speakers and Chairs, check out the websites linked below:
Sven Lindemann
Merck, Germany
Jane Smith
European Association for Cancer Research, UK
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Data
Your details will be retained in our electronic registration database and used for correspondence from the EACR in line with our Privacy Policy.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Don't Share
Share
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
Invoicing information
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
Confirm Registration